RxDoctor Payments Data

Karie Prokop

Physician Assistant · Wilmington, ILNPI 1447558127

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $49,158 of the $67,683 with a category attached, or 72.6%. 41 manufacturers reported payments, led by Nestle Healthcare Nutrition Inc. at 44.0% of the total. Reporting peaked in 2022 at $18,819 and has fallen 76.1% since, to $4,494 in 2025. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,683in general payments, 2019–2025

Across 818 payments — averaging $82.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nestle Healthcare Nutrition Inc.$30K
  • AbbVie$19K
  • Aimmune Therapeutics, Inc.$12K
  • AstraZeneca$1K
  • Novo Nordisk$750
  • Axsome Therapeutics, Inc.$550
  • plus $4K from 35 others

What the payments were for

  • Consulting fees$5001%
  • Speaking & faculty fees$49,15873%
  • Travel & lodging$5,9739%
  • Food & beverage$11,98118%
  • Education$720%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,683 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide35$37,244
OzempicSemaglutide25$34,606
MounjaroTirzepatide33$34,436
FarxigaDapagliflozin Propanediol22$20,392
JardianceEmpagliflozin15$17,833
VraylarCariprazine Hcl11$14,480
VyvanseLisdexamfetamine Dimesylate12$4,255
Metformin Hcl ErMetformin Hcl60$551
Losartan Potassium18$144
Telmisartan14$140
Amlodipine Besylate27$120
Atorvastatin Calcium19$59
Prednisone11$11

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$485$71,68068 claims
Novo NordiskOzempic$750$34,60625 claims
AstraZenecaFarxiga$1,148$20,39222 claims
Boehringer IngelheimJardiance$223$17,83315 claims
AbbVieVraylar$19,396$14,48011 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$102$4,25512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Wilmington

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →